• Saved

April 11, 2021

Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population - PubMed

Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33814336/

Despite improvements in therapy, approximately 5% of patients who undergo autologous stem cell transplantation (ASCT) experience early mortality (EM), death within 1 year of transplant (EM post-ASCT). Such patients tend to have few comorbidities suggesting their EM is owing to aggressive underlying ...

  • April 11, 2021
    Death within a year of autoSCT not only indicates a disease resistant to chemo but also novel agents given the prolonged pfs of triplet regimens in salvage. These patients have a unmet need that will be only partly fulfilled with recent approvals